Related Experiment Videos
Beta-catenin mutations in sporadic fundic gland polyps
Shigeki Sekine1, Tatsuhiro Shibata, Yuko Yamauchi
1Pathology Division, National Cancer Center Research Institute and Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Virchows Archiv : an International Journal of Pathology
|April 17, 2002
Summary
Genetic mutations in the beta-catenin gene contribute to the development of sporadic fundic gland polyps (FGPs). These findings reveal a common pathway for FGP development, similar to familial adenomatous polyposis.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Fundic gland polyps (FGPs) are the most common gastric polyps, occurring sporadically or with familial adenomatous polyposis (FAP).
- APC gene mutations are linked to FAP-associated FGPs, but less frequently in sporadic FGPs.
- APC gene inactivation leads to beta-catenin accumulation; beta-catenin gene mutations can have a similar effect.
Purpose of the Study:
- To investigate the role of beta-catenin gene mutations in the development of sporadic FGPs.
- To analyze mutations in exon 3 of the beta-catenin gene in sporadic FGP lesions.
Main Methods:
- Analysis of beta-catenin gene mutations in exon 3.
- Examined 45 FGP lesions from 35 patients.
- Sequencing to identify somatic mutations.
Main Results:
- Somatic mutations in the beta-catenin gene were identified in 29 of 45 sporadic FGP lesions.
- Mutations primarily involved missense mutations at GSK-3 beta phosphorylation sites in beta-catenin.
- Multiple FGPs within patients showed distinct mutations, suggesting multicentric origins.
Conclusions:
- A significant percentage of sporadic FGPs harbor genetic alterations that stabilize beta-catenin.
- This pathway of beta-catenin stabilization is common to both sporadic and FAP-associated FGPs.
- Beta-catenin gene mutations are a key factor in the histogenesis of sporadic FGPs.